Attached files
| file | filename |
|---|---|
| EX-99.1 - PRESS RELEASE DATED JULY 13, 2017 - XYNOMIC PHARMACEUTICALS HOLDINGS, INC. | f8k071317ex99i_bisoncapital.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 13, 2017
Bison Capital Acquisition Corp.
(Exact name of registrant as specified in its charter)
| British Virgin Islands | 001-38120 | N/A | ||
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
609-610 21st Century Tower
No.
40 Liangmaqiao Road
Chaoyang District, Beijing
China 100016
(Address of principal executive offices, including Zip Code)
(86) 10-8444-6968
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 8.01. Other Events
Separate Trading of Ordinary Shares, Warrants and Rights
On July 13, 2017, Bison Capital Acquisition Corp. (the “Company”) announced that the holders of the Company’s units (the “Units”) may elect to separately trade the securities underlying such Units commencing on or about July 17, 2017. Each Unit consists of one ordinary share, no par value (“Ordinary Share”), one-half of one warrant, each whole warrant to purchase one Ordinary Share, and one right to receive one-tenth (1/10) of one Ordinary Share upon the consummation of the Company’s initial business transaction. No fractional warrants will be issued upon separation of the Units and only whole warrants will trade. Any Units not separated will continue to trade on the NASDAQ Capital Market under the symbol “BCACU”. Any underlying Ordinary Shares, warrants and rights that are separated are expected to trade on the NASDAQ Capital Market under the symbols “BCAC,” “BCACW” and “BCACR,” respectively. Holders of Units will need to have their brokers contact Continental Stock Transfer & Trust Company, the Company’s transfer agent, in order to separate the holders’ Units into Ordinary Shares, warrants and rights.
A copy of the Press Release issued by the Company announcing the separate trading of the securities underlying the Units is attached hereto as Exhibit 99.1.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
| Exhibit No. | Description | |
| 99.1 | Press Release dated July 13, 2017 |
| 2 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: July 13, 2017
| Bison Capital Acquisition Corp. | ||
| By: | /s/ James Jiayuan Tong | |
| James Jiayuan Tong | ||
| Chief Executive Officer, Chief Financial Officer and Director | ||
3